Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention, JACC: Cardiovascular Interventions, vol.10, issue.20, pp.2017-2042, 2017. ,
DOI : 10.1016/j.jcin.2017.02.047
Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function: Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial, Circulation, vol.122, issue.11, pp.1056-67, 2010. ,
DOI : 10.1161/CIRCULATIONAHA.109.933796
URL : http://circ.ahajournals.org/content/circulationaha/122/11/1056.full.pdf
Cardiovascular Mortality in Chronic Kidney Disease Patients Undergoing Percutaneous Coronary Intervention Is Mainly Related to Impaired P2Y12 Inhibition by Clopidogrel, Journal of the American College of Cardiology, vol.57, issue.4, pp.399-408, 2011. ,
DOI : 10.1016/j.jacc.2010.09.032
URL : https://doi.org/10.1016/j.jacc.2010.09.032
Platelet reactivity after receiving clopi-dogrel compared with ticagrelor in patients with kidney failure treated with hemodialysis: a randomized crossover study ,
DOI : 10.1053/j.ajkd.2014.11.023